Friday, January 21, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Novavax anti-Covid-19 vaccine under study in Europe

Novavax anti-Covid-19 vaccine under study in Europe

Amsterdam, Nov 17 (Prensa Latina) The European Medicines Agency (EMA) began today, at the request of the European Union, the evaluation of the anti-Covid-19 vaccine of U.S. pharmaceutical Novavax.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

This investigation will be carried out on an accelerated schedule, the EMA indicated, and explained that the opinion on the marketing authorization could be issued in a matter of weeks, according to the Dutch press on Wednesday.

The vaccine, which could become the fifth to be licensed in the European Union, uses a different technology from those already validated worldwide.

It is an immunogen based on proteins that trigger a virus-free response, and can be stored at a temperature of between 2 and 8 degrees Celsius, which would ease its distribution.

The WEA noted that the fast evaluation is due to the need to seek alternatives to face the new wave of Covid-19 in Europe.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.